Portfolio company
Reme-D
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops molecular diagnostic kits for human and animal diseases to support healthcare providers and researchers in underserved regions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
Rapidemic
Rapidemic develops molecular point-of-care diagnostic tests for sexually transmitted infections, providing results for patients and clinicians without requiring laboratory infrastructure or external power.
4BASES
This company develops diagnostic genetic testing kits and sequencing reagents for healthcare professionals and clinical laboratories to support precision medicine and disease prevention.
DxLab
This company develops point-of-care molecular testing systems and rapid diagnostic tests for pathogens to serve healthcare providers and public health teams.
Range Bio
This company develops protein quantification tools for researchers and clinicians to improve diagnostic medicine and accelerate drug development.
BMTfemme
This company develops rapid antigen diagnostic tests and breast screening technology for healthcare providers and individual consumers.
Avelo
This company develops non-invasive breath sampling kits for the molecular diagnosis of respiratory infections like tuberculosis and pneumonia for clinicians and patients.
Limosa Immunodiagnostics
This company develops diagnostic tests for latent tuberculosis and other immune-related diseases for patients and healthcare providers.
